MOUNTAIN VIEW, Calif., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced today that Company management is planning to participate in the following investor conferences:
